United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a thymus—making them highly vulnerable to...
Search results for "cell therapy"
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for its landmark knee osteoarthritis...
Buying Time for Degenerative Knees: SVF Cell Therapy Cuts Osteoarthritis Pain in Three Weeks
As knee osteoarthritis worsens, total knee replacement surgery becomes an unavoidable reality for millions of aging...
Umbilical Cord-Derived Stem Cell Therapy Offers New Hope for Treatment-Resistant Hair Loss
For many individuals experiencing hair loss, investing significant time and money into treatments does not always...
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
The U.S. Food and Drug Administration has agreed to a significantly streamlined clinical path for Cartistem, a landmark...
Rethinking Hair Growth: A Discovery That Upends Medical Textbooks
For decades, medical textbooks have taught a singular explanation for hair growth: cells divide rapidly at the hair...
The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?
A, who has entered her mid-40s this year, has been feeling increasingly depressed when standing in front of the mirror...
Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine
Samsung Medical Center has been named the No. 5 hospital worldwide and No. 1 in South Korea for cancer treatment,...
Autologous Fat Injections Linked to Slower Knee Osteoarthritis Progression, Study Finds
Patients with moderate knee osteoarthritis who received injections of stromal vascular fraction isolated from their own...
Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US
Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4...